Market Place
Sourcing Support
Taysha Gene Therapies To Report Q2 2024 Results On August 12
05 Aug 2024 //
GLOBENEWSWIRE
Taysha Gene Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
05 Jul 2024 //
GLOBENEWSWIRE
Taysha Gene Therapies Announces Pricing Of Public Offering
26 Jun 2024 //
GLOBENEWSWIRE
Taysha Gene Therapies Announces Public Offering of Common Stock
25 Jun 2024 //
GLOBENEWSWIRE
Taysha To Present REVEAL Rett Syndrome Data At IRSF Meeting
12 Jun 2024 //
GLOBENEWSWIRE
Taysha Gene Reports Full Year 2023 Financial Results
19 Mar 2024 //
GLOBENEWSWIRE
Taysha Gene Therapies to Release Full-Year 2023 Financial Results
14 Mar 2024 //
GLOBENEWSWIRE
Taysha Gene Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
01 Mar 2024 //
GLOBENEWSWIRE
Taysha Gene Announces Updates to TSHA-102 Clinical Program in Rett Syndrome
29 Feb 2024 //
GLOBENEWSWIRE
After patient outcry, Taysha starts to offload drug programs
16 Feb 2024 //
ENDPTS
Taysha Gene Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
02 Feb 2024 //
GLOBENEWSWIRE
Taysha Gene Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
05 Jan 2024 //
GLOBENEWSWIRE
Taysha Gene Announces Expanded Eligibility in REVEAL Phase 1/2 Adult Trial
29 Nov 2023 //
GLOBENEWSWIRE
Taysha Gene Therapies Reports Third Quarter 2023 Financial Results
14 Nov 2023 //
GLOBENEWSWIRE
Taysha Gene Reports Data from Rett Syndrome Patient Dosed in Phase 1/2 Trial
14 Aug 2023 //
GLOBENEWSWIRE
Nasdaq threatens to delist Taysha Gene Therapies
08 Aug 2023 //
ENDPTS
Taysha Gene Provides Clinical Updates for Investigational Programs TSHA-120
28 Jun 2023 //
GLOBENEWSWIRE
Taysha Gene Therapies Reports First Quarter 2023 Financial Results
11 May 2023 //
GLOBENEWSWIRE
Taysha Gene Reports Fourth Quarter and Full Year 2022 Financial Results
28 Mar 2023 //
GLOBENEWSWIRE
Taysha Gene to Release Fourth Quarter and Full-Year 2022 Financial Results
15 Mar 2023 //
GLOBENEWSWIRE
Taysha Gene Therapies Makes Executive Leadership Changes
19 Dec 2022 //
CONTRACTPHARMA
Taysha CEO steps down after patent fights with patient families, job cuts
19 Dec 2022 //
ENDPTS
Taysha Gene Therapies Makes Executive Leadership Changes
19 Dec 2022 //
CONTRACTPHARMA
Taysha CEO steps down after patent fights with patient families, job cuts
19 Dec 2022 //
ENDPTS
Taysha Gene Therapies Announces Executive Leadership Changes
16 Dec 2022 //
GLOBENEWSWIRE
Taysha to Participate in JMP Securities Hematology and Oncology Summit
29 Nov 2022 //
GLOBENEWSWIRE
Taysha Gene Therapies Reports3Q 2022 Financial Results
08 Nov 2022 //
BIOSPACE
Taysha Gene Therapies to Release Third Quarter 2022 Financial Results
02 Nov 2022 //
GLOBENEWSWIRE
String of gene therapy deals spurs cautious optimism on Wall Street
01 Nov 2022 //
BIOPHARMADIVE
Taysha Announces Pricing of Public Offering of Common Stock
27 Oct 2022 //
GLOBENEWSWIRE
Community, NeuroBo healthcare gainers; Taysha, TransCode lead losers` pack
27 Oct 2022 //
SEEKING ALPHA
Taysha Gene Therapies Shares Slide After Stock Offering
27 Oct 2022 //
FIRSTWORDPHARMA
A biotech paused a gene therapy hatched by families. Now they want control
26 Oct 2022 //
ENDPTS
Taysha Gene Therapies Announces Proposed Public Offering of Common Stock
25 Oct 2022 //
GLOBENEWSWIRE
Taysha Gene Therapies Reports Q2 2022 Rusult and Provides Corporate Update
11 Aug 2022 //
GLOBENEWSWIRE
Taysha Gene Therapies to Release Second Quarter 2022 Financial Results
09 Aug 2022 //
GLOBENEWSWIRE
Taysha Gene Therapies to Participate in Upcoming August Investor Conferences
01 Aug 2022 //
GLOBENEWSWIRE
Taysha Gene Therapies to Participate in Upcoming William Blair Conference
06 Jul 2022 //
GLOBENEWSWIRE
Taysha Gene Therapies Announces Annual Stockholder Meeting
13 Jun 2022 //
GLOBENEWSWIRE
Taysha Gene Therapies to Participate in Upcoming June Investor Conferences
02 Jun 2022 //
GLOBENEWSWIRE
Taysha Gene Therapies Reports First Quarter 2022 Financial Results
16 May 2022 //
GLOBENEWSWIRE
Taysha Gene Therapies to Release First Quarter 2022 Financial Results
11 May 2022 //
GLOBENEWSWIRE
Taysha Gene Therapies Announces Presentations at ASGCT
10 May 2022 //
GLOBENEWSWIRE
Taysha Gene Therapies Receives ODD from EC for TSHA-120
03 May 2022 //
GLOBENEWSWIRE
Taysha Gene Therapies Announces Oral Presentations at the Upcoming 2022
25 Apr 2022 //
GLOBENEWSWIRE
Taysha Gene Therapies to Participate in Upcoming CGM & CTM Summit
18 Apr 2022 //
GLOBENEWSWIRE
Taysha lays off 35% of staff, narrows R&D focus
01 Apr 2022 //
FIERCEBIOTECH
Taysha Gene Therapies Reports Q4 and Full Year 2021 Financial Results
31 Mar 2022 //
BUSINESSWIRE
Taysha Gene to Initiate Clinical Development of TSHA-102 in Rett Syndrome
29 Mar 2022 //
BUSINESSWIRE
Taysha Gene Therapies to Release Q4 and Full-Year 2021 Financial Results
24 Mar 2022 //
BUSINESSWIRE
Taysha Gene Therapies to Participate in the Oppenheimer 32nd Conference
08 Mar 2022 //
BUSINESSWIRE
Taysha Announces Positive Safety Data from UT Southwestern-Sponsored Trial
09 Feb 2022 //
BUSINESSWIRE
Taysha Reports Positive Clinical Efficacy and Safety Data for TSHA-120
31 Jan 2022 //
BUSINESSWIRE
Taysha mulls tweaks to gene therapy trial after subject dies
28 Jan 2022 //
FIERCEBIOTECH
Taysha Gene Therapies to Present at 40th J.P. Morgan Healthcare Conference
06 Jan 2022 //
BUSINESSWIRE
Taysha Gene Therapies Added to the ICE Biotechnology Index
23 Dec 2021 //
BUSINESSWIRE
Taysha Gene Therapies Added to the ICE Biotechnology Index
23 Dec 2021 //
BUSINESSWIRE
Taysha Gene Therapies Announces +vePreliminary Clinical Safety Data CLN7 Disease
22 Dec 2021 //
BIOSPACE
Taysha Gene Therapies Announces Initiation of Clinical Development of TSHA-118
16 Dec 2021 //
BUSINESSWIRE
